An association between the impairment of endothelial nitric oxide synthase (eNOS) function and a decrease of NO production in non-alcoholic fatty liver disease (NAFLD) has been suggested [7,8]. The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatotic liver disease.